These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


106 related items for PubMed ID: 2268863

  • 1. Effects of simvastatin, an HMG-CoA reductase inhibitor, on plasma lipids and steroid hormones.
    Ide H, Fujiya S, Aanuma Y, Agishi Y.
    Clin Ther; 1990; 12(5):410-20. PubMed ID: 2268863
    [Abstract] [Full Text] [Related]

  • 2. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K, Sasaki J, Arakawa K.
    Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
    [Abstract] [Full Text] [Related]

  • 3. [Effects of simvastatin on plasma levels of lipids, lipoproteins and apolipoproteins in primary hypercholesterolemia].
    Caruzzo C, Uslenghi E, Varbella F, Caruzzo E, Marcolongo M, Brusca A.
    Minerva Cardioangiol; 1989 Dec; 37(12):509-15. PubMed ID: 2695857
    [Abstract] [Full Text] [Related]

  • 4. The effects of simvastatin on serum lipoproteins in severe hypercholesterolaemia.
    Mol MJ, Stuyt PM, Demacker PN, Stalenhoef AF.
    Neth J Med; 1990 Apr; 36(3-4):182-90. PubMed ID: 2355995
    [Abstract] [Full Text] [Related]

  • 5. Simvastatin in the treatment of hypercholesterolemia in elderly patients.
    Antonicelli R, Onorato G, Pagelli P, Pierazzoli L, Paciaroni E.
    Clin Ther; 1990 Apr; 12(2):165-71. PubMed ID: 2354486
    [Abstract] [Full Text] [Related]

  • 6. [Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia].
    Riesen WF, Keller U, Del Bufalo A, Reutter FW, Baur HR, Golay A, Bertel O, Kummer H, Kistler H, Ammann F.
    Schweiz Med Wochenschr; 1989 Dec 02; 119(48):1719-23. PubMed ID: 2694363
    [Abstract] [Full Text] [Related]

  • 7. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.
    Clin Ther; 2004 Sep 02; 26(9):1388-99. PubMed ID: 15531001
    [Abstract] [Full Text] [Related]

  • 8. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS, Bacon SP, Illingworth DR.
    J Lab Clin Med; 2003 Apr 02; 141(4):250-6. PubMed ID: 12677170
    [Abstract] [Full Text] [Related]

  • 9. Influence of cholesterol-lowering on plasma membrane lipids and function.
    Lijnen P, Echevaría-Vázquez D, Petrov V.
    Methods Find Exp Clin Pharmacol; 1996 Mar 02; 18(2):123-36. PubMed ID: 8740244
    [Abstract] [Full Text] [Related]

  • 10. Effect of simvastatin on plasma lipids, apolipoproteins and lipoprotein particles in patients with primary hypercholesterolaemia.
    Bard JM, Luc G, Douste-Blazy P, Drouin P, Ziegler O, Jacotot B, Dachet C, De Gennes JL, Fruchart JC.
    Eur J Clin Pharmacol; 1989 Mar 02; 37(6):545-50. PubMed ID: 2693115
    [Abstract] [Full Text] [Related]

  • 11. [Effect of a long-term treatment with simvastatin, an inhibitor of HMG-CoA reductase, in dyslipidemic patients at high risk].
    Strano A, Novo S, Notarbartolo A, Davì G, Abrignani MG, Alaimo G, Averna MR, Barbagallo CM, Marino G.
    Cardiologia; 1989 Dec 02; 34(12):1027-33. PubMed ID: 2634479
    [Abstract] [Full Text] [Related]

  • 12. Effects of simvastatin on serum lipids and atherosclerosis in WHHL rabbits.
    Fukuo Y, Nagashima M, Saitoh A, Kobayashi Y, Terashi A, Nakama K, Kameyama K, Asano G.
    Clin Ther; 1991 Dec 02; 13(3):417-24. PubMed ID: 1954642
    [Abstract] [Full Text] [Related]

  • 13. [Clinical evaluation of simvastatin in the treatment of hyperlipidemia].
    Lu ZL.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Aug 02; 21(4):216-8, 253. PubMed ID: 8194433
    [Abstract] [Full Text] [Related]

  • 14. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
    Moghadasian MH, Nguyen LB, Shefer S, Salen G, Batta AK, Frohlich JJ.
    Metabolism; 2001 Jun 02; 50(6):708-14. PubMed ID: 11398149
    [Abstract] [Full Text] [Related]

  • 15. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences].
    Geisel J, Oette K, Burrichter H.
    Fortschr Med; 1990 Feb 10; 108(4):71-2, 75-6. PubMed ID: 2312032
    [Abstract] [Full Text] [Related]

  • 16. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia.
    Farnier M, Bonnefous F, Debbas N, Irvine A.
    Arch Intern Med; 1994 Feb 28; 154(4):441-9. PubMed ID: 8117177
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of tolerance, efficacy and safety of 3-year simvastatin use in the treatment of primary hypercholesterolemia].
    Darioli R, Bovet P, Brunner HR, Bercher L.
    Schweiz Med Wochenschr; 1990 Jan 27; 120(4):85-91. PubMed ID: 2305221
    [Abstract] [Full Text] [Related]

  • 18. Effects of simvastatin, a cholesterol synthesis inhibitor, on phosphatidylcholine synthesis in HepG2 cells.
    Yanagita T, Yamamoto K, Ishida S, Sonda K, Morito F, Saku K, Sakai T.
    Clin Ther; 1994 Jan 27; 16(2):200-8. PubMed ID: 8062316
    [Abstract] [Full Text] [Related]

  • 19. Effects of simvastatin on lipoprotein (a) and lipoprotein composition in patients with nephrotic syndrome.
    Wanner C, Böhler J, Eckardt HG, Wieland H, Schollmeyer P.
    Clin Nephrol; 1994 Mar 27; 41(3):138-43. PubMed ID: 8187355
    [Abstract] [Full Text] [Related]

  • 20. [Effects of simvastatin on plasma lipoproteins].
    Alessandri C, Basili S, Maurelli M, Andreozzi P, Bracaglia D, Cordova C.
    Clin Ter; 1994 Jan 27; 144(1):3-9. PubMed ID: 8168349
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.